Sign In
Buy TGT
$149.70
+2.61 (+1.77%)
At Close: Aug 07, 2026
NETSOL Technologies Reports 19% Revenue Growth in Fiscal Fourth Quarter of 2024 and Exceeds Full Fiscal Year 2024 Revenue Target
04:05pm, Monday, 30'th Sep 2024
ENCINO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK ), a global business services and asset finance solutions provider, reported results for the fourth quarter a
Meta Stock Nabs Another Price-Target Hike Following Connect AI, Metaverse Event
12:21pm, Monday, 30'th Sep 2024
Meta stock received another price target hike early Monday, as analysts review last week's AI, metaverse event.
Nurix Therapeutics Announces Presentations at Discovery on Target Conference
07:00am, Monday, 30'th Sep 2024
SAN FRANCISCO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat pat
15 Best Dividend Stocks for Lifelong Passive Income
06:15am, Monday, 30'th Sep 2024
Dividend sustainability trumps high yields when selecting stocks for passive income. The featured companies span diverse sectors including healthcare, consumer goods, retail, finance, and real estate.
The Fed Just Lowered Interest Rates. My Top Dividend King Stock to Buy Now.
04:15am, Monday, 30'th Sep 2024
When interest rates are high, income investors may gravitate toward risk-free products and away from dividend stocks. Target's results have improved, but it still has more work to do.
Top Wall Street analysts prefer these dividend stocks to strengthen portfolios
07:03am, Sunday, 29'th Sep 2024
TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Darden Restaurants and Target
Billionaires Are Selling Costco. These 2 Retail Stocks Are Better Buys.
03:36am, Saturday, 28'th Sep 2024
Costco has been a big winner, but the stock is looking pricey. Home Depot looks poised to gain as interest rates fall.
My Best Dividend Aristocrats For October 2024
09:19am, Friday, 27'th Sep 2024
The ProShares S&P 500 Dividend Aristocrats ETF extends it's good form in the second half of 2024, adding a gain of 3.69% in August. I present 3 strategies that can theoretically beat the dividend aris
Target (TGT) Surpasses Market Returns: Some Facts Worth Knowing
06:50pm, Thursday, 26'th Sep 2024
Target (TGT) closed at $155.98 in the latest trading session, marking a +0.59% move from the prior day.
Amazon Tops Internal $1.8B Target For Upfront Ad Revenue In First Year Of Prime Video Push
05:01pm, Thursday, 26'th Sep 2024
Amazon's video ad revenue for the 2024-25 upfront period has exceeded the tech giant's internal target of $1.8 billion, a person familiar with the financials has confirmed to Deadline.
With Just a 6% Gain in 3 Months, Should You Hold or Sell Target Stock?
04:01pm, Thursday, 26'th Sep 2024
Despite challenges, Target's ability to attract and retain customers through its value-driven approach and loyalty programs signals resilience.
TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) is pleased to announce that surface rock sampling has encountered gold with associ
Relevant Gold Defines Large-Scale Drilling Target at Bradley Peak, Sampling 46.8 g/t Au, 7.8% Cu and 2% Zn in Apex Zone
06:30am, Thursday, 26'th Sep 2024
VANCOUVER, BC / ACCESSWIRE / September 26, 2024 / Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) (the "Company" or "Relevant Gold") announces final results from its 2024 geologic mapping and rock chip sa
Target Circle Week Returns Oct. 6-12 with Seven Days of Deals Up to 50% Off
06:01am, Thursday, 26'th Sep 2024
Members of free-to-join Target Circle can save on thousands of items including fall favorites, entertaining must-haves and get an early start on holiday shopping The member-favorite Deal of the Da
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
03:50pm, Wednesday, 25'th Sep 2024
Last week, Ascendis Pharma A/S ASND released topline data on Monday from a trial that included 84 children with achondroplasia, a genetic disorder that causes dwarfism and disproportionate short stat
